---
title: "RBC Capital Reaffirms Their Buy Rating on Lonza Group Ltd (LONN)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283956942.md"
description: "RBC Capital has reaffirmed a Buy rating on Lonza Group Ltd (LONN) with a price target of CHF670.00, as stated by analyst Charles Weston. Despite an average return of -6.6% and a 35.34% success rate, Weston continues to cover the Healthcare sector. Barclays also maintained a Buy rating for the stock with the same price target of CHF670.00."
datetime: "2026-04-24T06:55:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283956942.md)
  - [en](https://longbridge.com/en/news/283956942.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283956942.md)
generator: "portal-rs"
---

# RBC Capital Reaffirms Their Buy Rating on Lonza Group Ltd (LONN)

In a report released today, Charles Weston from RBC Capital reiterated a Buy rating on Lonza Group Ltd, with a price target of CHF670.00.

### Claim 30% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Weston is an analyst with an average return of -6.6% and a 35.34% success rate. Weston covers the Healthcare sector, focusing on stocks such as Oxford BioMedica, Siegfried Holding AG, and Oxford Nanopore Technologies PLC.

In a report released on April 21, Barclays also maintained a Buy rating on the stock with a CHF670.00 price target.

### Related Stocks

- [LZAGY.US](https://longbridge.com/en/quote/LZAGY.US.md)
- [O6Z.SG](https://longbridge.com/en/quote/O6Z.SG.md)
- [RY.US](https://longbridge.com/en/quote/RY.US.md)
- [OXB.UK](https://longbridge.com/en/quote/OXB.UK.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)

## Related News & Research

- [Lonza enlists returning exec for new commercial chief post](https://longbridge.com/en/news/297553743.md)
- [CLSA: Global Pharma Supply Chain Enters Decade-long Restructuring; Prefers Platform Leaders Including Thermo Fisher Scientific Inc , WUXI APPTEC](https://longbridge.com/en/news/297863665.md)
- [Morgans Remains a Buy on EchoIQ Limited (EIQ)](https://longbridge.com/en/news/297720502.md)
- [09:01 ETHealthcare Is Moving Into the Home. Home Accessibility Now Has a Validated Score.](https://longbridge.com/en/news/297656740.md)
- [Iconovo enters strategic collaboration agreement with Lonza on spray-dried inhaled formulations](https://longbridge.com/en/news/296445004.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**